Quality Management and Animal Welfare as Culture of Care for Animal Experiments under Biosafety Level-3, taking COVID-19 as a Practical Example

Since the start of the COVID‐19 pandemic, a tremendous amount of work has been done by scientists to understand the pathogenesis of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Several animal models have been reported to be useful for the development and testing of vaccines, ant...

Full description

Saved in:  
Bibliographic Details
Authors: Richter, Armina (Author) ; Wirz, Katrin (Author) ; Pilchová, Veronika (Author) ; Schulz, Claudia 1968- (Author) ; Volz, Asisa (Author) ; Köckritz-Blickwede, Maren von (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Brill 2024
In: Journal of applied animal ethics research
Year: 2024, Volume: 6, Issue: 1, Pages: 26-52
Further subjects:B 3S
B animal husbandry
B Severe acute respiratory syndrome-related coronavirus 2
B data management
B inactivation
B culture of care
B BSL
B biosafety level
B Housing
B 3R
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1895372747
003 DE-627
005 20240714034554.0
007 cr uuu---uuuuu
008 240713s2024 xx |||||o 00| ||eng c
024 7 |a 10.1163/25889567-bja10047  |2 doi 
035 |a (DE-627)1895372747 
035 |a (DE-599)KXP1895372747 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 0  |a 1  |2 ssgn 
100 1 |a Richter, Armina  |e VerfasserIn  |4 aut 
245 1 0 |a Quality Management and Animal Welfare as Culture of Care for Animal Experiments under Biosafety Level-3, taking COVID-19 as a Practical Example 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Since the start of the COVID‐19 pandemic, a tremendous amount of work has been done by scientists to understand the pathogenesis of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Several animal models have been reported to be useful for the development and testing of vaccines, antivirals, or therapeutics. These in vivo experiments have to be performed at high containment biosafety level (BSL)-3. Thus, an appropriate biosafety, facility and data management as well as high standard of animal welfare, thorough study design, and staff training combined with an overall research transparency and open communication need to be implemented to achieve high quality reproducible research. Such an approach combined with the well-known 3R principle (Replacement, Reduction, and Refinement) and the 3S principle (Good Science, Good Sense, and Good Sensibilities) can contribute to culture of care in scientific research. The perspective reviews the key points of optimized biosafety, data, quality and animal welfare management in high risk biosafety-settings to conduct animal experiments with infectious pathogens in the context of a culture of care. 
601 |a COVID-19 
650 4 |a SARS-CoV-2 
650 4 |a inactivation 
650 4 |a Housing 
650 4 |a data management 
650 4 |a culture of care 
650 4 |a BSL 
650 4 |a biosafety level 
650 4 |a animal husbandry 
650 4 |a 3S 
650 4 |a 3R 
700 1 |a Wirz, Katrin  |e VerfasserIn  |0 (orcid)0009-0002-1840-0363  |4 aut 
700 1 |a Pilchová, Veronika  |e VerfasserIn  |4 aut 
700 1 |e VerfasserIn  |0 (DE-588)124390005  |0 (DE-627)363314326  |0 (DE-576)294150137  |4 aut  |a Schulz, Claudia  |d 1968- 
700 1 |a Volz, Asisa  |e VerfasserIn  |4 aut 
700 1 |a Köckritz-Blickwede, Maren von  |e VerfasserIn  |0 (orcid)0000-0001-7712-9767  |4 aut 
773 0 8 |i Enthalten in  |t Journal of applied animal ethics research  |d Leiden : Brill, 2019  |g 6(2024), 1, Seite 26-52  |h Online-Ressource  |w (DE-627)168461418X  |w (DE-600)3002529-1  |x 2588-9567  |7 nnns 
773 1 8 |g volume:6  |g year:2024  |g number:1  |g pages:26-52 
856 4 0 |u https://doi.org/10.1163/25889567-bja10047  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://brill.com/abstract/journals/jaae/6/1/article-p26_3.xml  |x Verlag  |z lizenzpflichtig  |3 Volltext 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4550740280 
LOK |0 003 DE-627 
LOK |0 004 1895372747 
LOK |0 005 20240713055505 
LOK |0 008 240713||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2024-07-12#194E6DE9AD682011C3AB62CAF6447743A54D2161 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a zota 
ORI |a SA-MARC-ixtheoa001.raw 
REL |a 1 
STA 0 0 |a Severe acute respiratory syndrome-related coronavirus 2 
STB 0 0 |a SARS-CoV-2 (virus) 
STC 0 0 |a SARS-CoV-2 
STD 0 0 |a SARS-CoV-2,SARS-CoV-2 
STF 0 0 |a 嚴重急性呼吸綜合症冠狀病毒2型 
STG 0 0 |a Coronavírus da síndrome respiratória aguda grave 2 
STH 0 0 |a SARS-CoV-2 
STI 0 0 |a SARS-CoV-2 
SUB |a REL 
SYE 0 0 |a Schweres akutes Atemwegssyndrom Coronavirus 2,Severe acute respiratory syndrome coronavirus 2,2019-nCoV,2019-novel Corona virus,Wuhan-Coronavirus